Technical Analysis for NSCI - Netscientific Plc
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 63.00 | 0.00% | 0.00 |
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
200 DMA Support | Bullish | 0.00% | |
Hammer Candlestick | Bullish | 0.00% | |
Doji - Bearish? | Reversal | 0.00% | |
Doji - Bullish? | Reversal | 0.00% | |
200 DMA Support | Bullish | 0.00% | |
Doji - Bearish? | Reversal | 0.00% | |
200 DMA Support | Bullish | 0.00% | |
Hammer Candlestick | Bullish | 0.00% | |
MACD Bullish Signal Line Cross | Bullish | 0.00% | |
Doji - Bearish? | Reversal | 0.00% |
Alert | Time |
---|---|
Fell Below Previous Day's Low | about 16 hours ago |
Down 3% | about 16 hours ago |
Down 2% | about 16 hours ago |
Down 1% | about 16 hours ago |
Fell Below 200 DMA | about 16 hours ago |
Get a Trading Assistant
Netscientific Plc Description
NetScientific plc is a transatlantic healthcare technology company. The Company develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in the United States and Europe with a primary focus on diagnostics, digital health and therapeutics. The Company is engaged in the development of intellectual property. Its portfolio consists of WANDA Health, an analytics company that uses machine learning to derive a personalized risk score for Congestive Heart Failure patients; Glucosense, a provider of a non-invasive glucose monitoring wearable device; Vortex Biosciences, which is engaged in circulating tumor cell identification, selection and analysis for disease monitoring and personalized therapeutic prescribing; Glycotest, which provides non-invasive blood tests for liver cancers and fibrosis-cirrhosis, and ProAxsis, which is engaged in respiratory disease diagnosis and treatment monitoring.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Healthcare Medicine Science Cancer Disease Ships Monitoring Clinical Medicine Analytics Earl Identification Partnerships Intellectual Property Machine Learning Blood Healthcare Technology Respirator Tumor Cancers Learning Respiratory Disease E Learning Fibrosis Heart Failure Blood Tests Circulating Tumor Cell Congestive Heart Failure Liver Cancer
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 78.75 |
52 Week Low | 48.0 |
Average Volume | 28,455 |
200-Day Moving Average | 62.04 |
50-Day Moving Average | 66.74 |
20-Day Moving Average | 63.78 |
10-Day Moving Average | 63.20 |
Average True Range | 2.49 |
RSI (14) | 43.82 |
ADX | 17.16 |
+DI | 13.73 |
-DI | 22.23 |
Chandelier Exit (Long, 3 ATRs) | 61.72 |
Chandelier Exit (Short, 3 ATRs) | 65.48 |
Upper Bollinger Bands | 67.87 |
Lower Bollinger Band | 59.68 |
Percent B (%b) | 0.41 |
BandWidth | 12.83 |
MACD Line | -1.07 |
MACD Signal Line | -1.15 |
MACD Histogram | 0.0831 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 66.00 | ||||
Resistance 3 (R3) | 65.67 | 64.33 | 65.50 | ||
Resistance 2 (R2) | 64.33 | 63.57 | 64.50 | 65.33 | |
Resistance 1 (R1) | 63.67 | 63.10 | 64.00 | 64.00 | 65.17 |
Pivot Point | 62.33 | 62.33 | 62.50 | 62.50 | 62.33 |
Support 1 (S1) | 61.67 | 61.57 | 62.00 | 62.00 | 60.83 |
Support 2 (S2) | 60.33 | 61.10 | 60.50 | 60.67 | |
Support 3 (S3) | 59.67 | 60.33 | 60.50 | ||
Support 4 (S4) | 60.00 |